What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for a specific lot of CAREone ear drops distributed by Bell Pharmaceuticals, Inc. This action involves the product identified as Carbamide Peroxide 6.5%, packaged in 0.5 fluid ounce (15 mL) bottles. The National Drug Code (NDC) for this specific recalled item is 72476-838-34. While Bell Pharmaceuticals, Inc. is the brand manufacturer, the product was distributed by FOODHOLD U.S.A, LLC, located in Landover, Maryland. Consumers who purchased ear drops from various retailers across the country during the relevant sales period may have this specific item in their medicine cabinets.
The precise details of the recall are tied to a single lot number: 1505141. This lot is marked with an expiration date of April 2027. It is important to note that while the product was manufactured and distributed under the CAREone brand, the specific batch involved in this safety notice is identified by the lot number 1505141. The distribution pattern for this recall was nationwide, meaning these bottles were sold in all 50 states, including Minnesota, rather than being limited to a specific regional market. This broad distribution is why the FDA has taken the step of issuing a Class II recall, which covers products that might cause temporary health problems or pose slight threat of serious disease.
The scope of this recall is defined by the physical characteristics of the product. The recalled items are small, clear bottles containing 0.5 FL OZ (15 mL) of liquid ear drops. These bottles were labeled with the NDC 72476-838-34 and distributed under the authority of FOODHOLD U.S.A, LLC in Landover, MD 20785. If you have a bottle of CAREone Carbamide Peroxide 6.5% that matches this description, you must check the lot number printed on the packaging to confirm if it falls within the recalled range. The recall was announced on June 25, 2026, indicating that this is a recent development in the oversight of over-the-counter ear care products.
Understanding the exact parameters of this recall helps consumers avoid unnecessary panic while ensuring they take the right steps. This is not a recall of every CAREone product ever made, nor is it a recall of all Carbamide Peroxide ear drops from Bell Pharmaceuticals. It is strictly limited to the specific lot 1505141 of the 0.5 FL OZ bottle with NDC 72476-838-34. By focusing on these precise identifiers, you can quickly determine whether your home inventory is affected. The nationwide distribution pattern underscores the importance of checking your local pharmacy receipts or online purchase histories from the time this product was available for sale.
The hazard, explained
To understand why this recall matters, we need to look closely at what is physically inside the bottle of CAREone Carbamide Peroxide. This product is designed to be a topical otic solution, meaning it is intended for use in the ear canal. The active ingredient, carbamide peroxide, works through a specific chemical process: when it comes into contact with moisture in the ear, it breaks down to release oxygen bubbles. These bubbles are supposed to help soften and lift away excess wax or debris. However, in this specific recall involving Lot 1505141 distributed by Foodhold U.S.A., LLC, that chemical balance has gone significantly wrong.
The core issue identified by the FDA is a dual failure in the product’s formulation. First, the assay—the measurement of how much actual active drug is present—has dropped to approximately 0.6%. This is drastically lower than the expected concentration of roughly 6.7% listed on the label. For context, this means the solution is roughly ten times weaker than intended. While one might assume that a weaker product is simply less effective, the second part of the problem makes it potentially harmful. The recall notice highlights that the product has a "subpotent" status due to a significantly reduced pH level.
Why does low pH matter in an ear drop? The human ear canal and eardrum are sensitive tissues that rely on a specific, nearly neutral pH environment to function correctly and resist infection. When a solution meant for the ear has an abnormally low pH (meaning it is more acidic than it should be), it can cause direct chemical irritation. This acidity can sting, burn, or inflame the delicate skin of the ear canal. In severe cases, applying an overly acidic substance to the ear can lead to contact dermatitis or exacerbate existing conditions like otitis externa, also known as swimmer’s ear.
The combination of these two factors creates a unique risk profile. Because the active ingredient is so weak (~0.6% vs ~6.7%), users may find that the product does not do its job—it will not soften wax or clean the ear effectively. This might lead them to use it more frequently or in larger quantities than recommended, hoping for results. If they continue to apply this acidic, ineffective solution repeatedly, they risk causing cumulative irritation to the ear canal without gaining any therapeutic benefit. Essentially, you are exposing a sensitive area to a chemical irritant that fails to perform its intended mechanical function.
It is important to note that while the recall classifies this as a Class II event—meaning it is unlikely to cause serious adverse health consequences or death—the potential for pain, discomfort, and secondary infection remains real. The hazard here is not necessarily an immediate toxicity from overdose, but rather a failure of product integrity that turns a helpful tool into a source of unnecessary physical stress and chemical irritation for the user.
Who is most at risk
Understanding who is most vulnerable to this specific recall requires looking closely at both the intended users of the product and the unique nature of the defect. The recalled item, CAREone Carbamide Peroxide 6.5%, is primarily distributed for use as a home teeth-whitening agent. Therefore, the group immediately at risk includes anyone who has purchased, received as a gift, or currently possesses this specific bottle from Foodhold U.S.A., LLC. While the product is marketed toward consumers seeking cosmetic dental improvements, the safety implications of the defect extend beyond simple aesthetic disappointment.
The core hazard here is that the drug is "SubPotent," meaning it contains significantly less active ingredient than labeled—approximately 0.6% compared to the expected 6.5%. While one might initially think that a weaker product is simply ineffective, the specific nature of this defect introduces a different kind of risk related to chemical balance. The recall notice highlights that the product also has a "low pH." Carbamide peroxide works by breaking down into hydrogen peroxide and urea to whiten teeth; when the chemical stability is compromised by low pH, the solution may not behave as intended. For users who rely on this product for consistent whitening results, there is a risk that they may inadvertently overuse the product in an attempt to achieve desired effects, leading to potential gum irritation or tooth sensitivity without the expected benefits.
Certain demographics are particularly vulnerable to these chemical imbalances. Individuals with pre-existing dental conditions, such as sensitive teeth, receding gums, or open cavities, are at higher risk for adverse reactions. Even a mild deviation in pH can cause significant discomfort or tissue irritation for those with compromised oral health barriers. Furthermore, while this product is generally intended for adult use, households with children require extreme caution. Although the low potency reduces the risk of severe chemical burns compared to a full-strength concentration, any unregulated chemical substance should never be accessible to minors due to the risk of accidental ingestion or improper application.
Elderly users may also face heightened risks if they have underlying health conditions that affect their ability to tolerate changes in oral pH levels. Additionally, because this recall is nationwide and distributed through various channels, there is a possibility that individuals who purchased the product months ago are still using it without realizing its potency has degraded. The lack of a stated remedy means that users cannot simply exchange it at a store; they must proactively identify if their lot number (1505141) matches the recall and cease use immediately. Ignoring the status of the product leaves these vulnerable groups exposed to unpredictable chemical interactions in the mouth, where tissue absorption can be rapid and sensitive.
How to tell if you have the recalled item
Identifying whether your ear care product is part of this specific recall requires a close and careful inspection of the packaging. Because the issue involves a pharmaceutical product distributed through retail channels, simply knowing the brand name is not enough to determine safety. You must verify several specific details printed on the bottle label against the official recall data. The process can feel tedious, but it is the only reliable way to ensure you are not using a subpotent medication that may not work as intended.
First, locate the physical bottle in your home. The recalled item is CAREone, which is manufactured by Bell Pharmaceuticals, Inc. Look at the front of the bottle to confirm the brand name. Next, check the active ingredient listing. It must read Carbamide Peroxide 6.5%. This is a common concentration for ear wax removal drops, so do not assume all bottles with this percentage are safe or unsafe; you must look at the other identifiers.
The most critical step is to find the National Drug Code (NDC) and the lot number. These are typically printed on the back or side of the bottle label. The recalled NDC is 72476-838-34. If your bottle has a different NDC, it is not part of this specific recall batch. Alongside the NDC, you must find the lot number. The specific lot identified in this FDA action is 1505141. Check the expiration date as well; the recalled product expires on 2027-04. While an expiration date alone does not confirm a recall, it helps narrow down the timeline of when the product was likely purchased.
You should also verify the volume and distributor information. The recalled bottles contain 0.5 FL OZ (15 mL) of liquid. The packaging should indicate that the product was distributed by FOODHOLD U.S.A, LLC, located in Landover, MD 20785. If your bottle lists a different distributor or manufacturer address, it is not included in this recall notice.
If you have purchased ear drops recently from any major retailer across the United States, there is a possibility your item is affected, as the distribution pattern for this recall is nationwide. However, if you cannot find the lot number 1505141 or the NDC 72476-838-34 on your bottle, you can be confident that your product is not part of this specific safety alert. When in doubt, compare your bottle directly against these details or contact the manufacturer for clarification.
What to do — step by step
If you are reading this because you might have a bottle of the recalled CAREone Carbamide Peroxide product, your immediate priority is to ensure your safety and then navigate the administrative side of the recall with clarity. The most critical first step is straightforward: stop using the product immediately. Because this specific batch from Bell Pharmaceuticals, Inc., distributed by Foodhold U.S.A., LLC, has been classified as a Class II recall due to being "subpotent," continuing to use it will not provide the therapeutic benefits you expect. The FDA’s investigation revealed that the product contains significantly reduced active ingredients—roughly 0.6% compared to the expected 6.5%. While this means the drug is unlikely to cause acute harm through toxicity, it also means it is effectively useless for its intended purpose, such as treating ear conditions or providing oral hygiene relief. Do not wait for symptoms to change; simply discontinue use right now.
The next phase involves dealing with the physical product in your home. Please locate the specific bottle you suspect is part of this recall. You can verify this by checking the label for the National Drug Code (NDC) 72476-838-34 and the lot number 1505141, which expires on April 2, 2027. Once confirmed, do not attempt to flush it down the toilet or throw it in the regular trash where it might be retrieved by others. Instead, follow standard local guidelines for disposing of unused medications if you cannot return it. If you are able to return it, keep the bottle intact with its label attached so that the specific details are visible. This helps authorities track the extent of the distribution pattern, which covers the entire United States.
Regarding your financial recourse, there is an important detail you need to know upfront: the official recall notice does not currently state a specific remedy for refunds, replacements, or repairs. This is not uncommon in Class II recalls where the primary hazard is efficacy rather than safety. The FDA’s main concern here was that the product did not work as labeled. Because a formal refund process has not been explicitly outlined in the public data, you should contact Bell Pharmaceuticals, Inc., or their distributor, Foodhold U.S.A., LLC, directly to inquire about any potential reimbursement policies they may have established internally. Keep your receipt and the product packaging safe until you speak with them.
Finally, if you used this product recently and have concerns about whether it treated your condition effectively, please consult your healthcare provider. They can advise you on alternative treatments that are confirmed to be potent and effective. Ignoring the recall does not pose a direct health risk in terms of poisoning, but it does mean your underlying issue may remain untreated. Stay informed by checking the FDA’s website for any updates to this recall notice, as remedy details could be added if the company decides to offer compensation in the future.
Your refund, repair, or replacement options
When you encounter a product recall, especially one involving pharmaceuticals, the immediate question is almost always about the remedy: "What happens next?" In the case of this specific FDA Class II recall involving Bell Pharmaceuticals’ CAREone Carbamide Peroxide 6.5% ear drops, the official recall facts do not currently state a specific remedy such as a direct refund, replacement, or repair program. This absence of explicit remediation details in the public record is not uncommon for certain Class II recalls, particularly when the hazard is classified as "subpotent" rather than toxic or contaminated. However, this does not mean you are left without recourse. Understanding your options requires looking at both the official guidance and your consumer rights.
First, it is important to clarify that because the identified hazard is that the drug is subpotent—meaning the carbamide peroxide concentration is significantly lower than the labeled 6.5% due to low pH and reduced assay—the product is not considered immediately dangerous in a toxicological sense. Instead, it is ineffective. You cannot "repair" ear drops; they are single-use, sterile (or intended for sterile use) chemical formulations. Therefore, repair is not an option. Your primary options revolve around getting your money back or obtaining a functional alternative.
The recall notice identifies Foodhold U.S.A., LLC of Landover, MD, as the distributor. While the official FDA alert does not list a specific toll-free number or website for this particular lot (Lot 1505141), the standard protocol for consumer remedies in such cases is to contact the distributor directly. You should reach out to Foodhold U.S.A., LLC to inquire about their internal return policy for recalled lots. Even if they do not have a formal "recall reimbursement" program, many distributors will process a refund or exchange for defective or recalled inventory upon verification of the lot number and expiration date (April 2027).
If you purchased the product from a retail pharmacy or store, your first step should be to return the item to the point of purchase with your receipt. Retailers often have their own protocols for handling recalled pharmaceuticals, which may include an immediate refund or store credit. This is often the fastest way to resolve the issue without needing to navigate distributor logistics. Keep in mind that because this is a Class II recall, the FDA’s primary goal is prevention of adverse health consequences through ineffectiveness, not necessarily managing a massive financial restitution program.
If you cannot locate your receipt or if the retailer refuses to help, document everything. Take photos of the bottle, the lot number (1505141), and the expiration date. Keep records of any communication with Foodhold U.S.A., LLC. If you believe you have suffered harm due to relying on this subpotent product for a medical condition, consult your healthcare provider. They may recommend an alternative treatment at no cost to you as part of their standard of care, which effectively serves as a non-monetary remedy for the inconvenience and potential health delay.
- Contact Foodhold U.S.A., LLC directly to ask about remedies for Lot 1505141.
- Return the product to your original retailer with proof of purchase for a refund.
- If no remedy is offered, consider the loss the cost of ineffective medication and dispose of the product safely.
What can happen if you ignore it
When you receive notice of a Class II recall involving a pharmaceutical product like CAREone Carbamide Peroxide, it is natural to feel a mix of frustration and concern. However, the most important step you can take is to stop using the product immediately. Ignoring this recall does not merely mean missing out on a refund or replacement; it means continuing to expose your health to a substance that has been verified by the FDA as unsafe for its intended purpose. While the recall classification is Class II—indicating that use of the product may cause temporary health problems or pose only a slight threat of serious nature—the consequences of ignoring the warning are still significant and should not be taken lightly.
The specific hazard identified in this recall is that the drug is "subpotent," meaning it contains significantly less active ingredient than it claims to have. The FDA’s investigation found that the assay (the measurement of the active ingredient) was only about 0.6%, compared to the expected 6.5%. In plain terms, you are getting less than one-tenth of the medicine you are paying for and relying on. For a product designed to treat ear conditions, such as wax removal or minor infections, this failure is not just an inconvenience; it is a treatment failure. By continuing to use this bottle, you are effectively leaving your condition untreated. If you were using CAREone to manage pain, reduce inflammation, or clear wax buildup, that process has stalled because the active chemical agent is virtually absent.
Beyond the immediate lack of therapeutic benefit, there are secondary risks associated with ignoring a subpotent drug recall. First, there is the risk of delayed recovery. If you have an underlying ear issue that requires proper treatment, relying on this ineffective product allows the condition to persist or potentially worsen. What might have been a minor, easily treatable problem could become a more serious infection if left unaddressed by effective medication. Second, while the primary issue here is low potency, the report also notes a "low pH." Products with incorrect pH levels can irritate the sensitive skin of the ear canal. Continued application of an improperly formulated solution may lead to contact dermatitis, itching, redness, or further inflammation, compounding the original problem you were trying to solve.
It is crucial to understand that "no reported incidents" in a recall notice does not mean no harm can occur; it simply means that no adverse events have been formally documented and reported to the agency yet. Subpotent drugs are insidious because they often do not cause an immediate, obvious allergic reaction or toxic spike. Instead, they fail silently. You might use the drops for several days, feel no relief, and assume the product just "doesn't work for you," rather than realizing it is fundamentally defective. This delay in recognizing the defect means you are wasting valuable time that could be spent seeking proper medical care. Ignoring the recall also risks spreading uncertainty about your health status to healthcare providers. If you later see a doctor for an ear issue, they need to know what products you have been using. Telling them you used a recalled, subpotent drug helps them understand why previous treatments may have failed and guides them toward more effective solutions.
Finally, consider the broader implication of using unverified pharmaceutical supplies. The FDA recalls are based on rigorous testing to ensure that every bottle meets strict safety and efficacy standards. By ignoring this recall, you are bypassing those safeguards. You are essentially gambling with your health for a product that has already been deemed unreliable by federal authorities. The peace of mind that comes from using a verified, effective treatment is worth far more than the effort it takes to dispose of the old bottle and obtain a replacement or refund. Do not let the inconvenience of the recall process outweigh the clear and present risk of continuing to use a drug that is not doing its job.
Staying safe: broader tips
When dealing with over-the-counter medications and health supplements, particularly those involving chemical compounds like carbamide peroxide, vigilance is your best defense. While manufacturers undergo rigorous quality control processes, the pharmaceutical supply chain is complex, and errors can occasionally slip through to consumers. The most effective way to protect yourself is to treat every product you bring into your home as a potential variable that requires verification. This does not mean living in fear; rather, it means adopting a habit of mindful consumption where you actively check labels, lot numbers, and expiration dates before use. For products intended for internal or delicate external use, such as ear drops or dental gels, even minor deviations in potency can alter how the product interacts with your body’s tissues.
One of the most practical steps you can take is to register your purchases whenever possible. Many manufacturers and third-party services offer email alerts that notify you directly if a specific lot number you own is subject to a recall. Since distribution patterns for medical products are often nationwide, waiting for news reports may not be fast enough to prevent use. By registering your purchase at the time of buying, or simply keeping digital receipts linked to your email, you create a personal safety net that operates independently of media coverage. This proactive approach ensures that if a manufacturer identifies a stability issue or a labeling error post-release, you are among the first to know.
Beyond recalls, understanding how to store these products correctly is critical to maintaining their intended safety profile. Chemical compounds like carbamide peroxide can degrade when exposed to fluctuating temperatures, direct sunlight, or humidity. Improper storage can lead to subpotency or, in some cases, the formation of unstable byproducts. Always follow the manufacturer’s storage instructions precisely, typically keeping such items in a cool, dry place away from bathrooms where steam levels are high. Additionally, never use any product that has changed color, odor, or consistency from its original state, as these are physical signs that the chemical integrity may have been compromised.
Finally, maintain open lines of communication with your healthcare providers regarding any over-the-counter products you use regularly. Pharmacists and doctors can provide context on what to look for in terms of side effects versus expected mild reactions. If you experience unexpected symptoms after using a new batch of a familiar product, discontinue use immediately and consult a professional. This habit of pausing to evaluate rather than assuming continuity helps catch issues early, whether they stem from a manufacturing defect, a storage error, or an individual sensitivity. By combining registration alerts with proper storage and professional guidance, you significantly reduce the risk associated with any consumer health product.